ID   ENOG_HUMAN              Reviewed;         434 AA.
AC   P09104; B7Z2X9; Q96J33;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JAN-2024, entry version 249.
DE   RecName: Full=Gamma-enolase;
DE            EC=4.2.1.11;
DE   AltName: Full=2-phospho-D-glycerate hydro-lyase;
DE   AltName: Full=Enolase 2;
DE   AltName: Full=Neural enolase;
DE   AltName: Full=Neuron-specific enolase;
DE            Short=NSE;
GN   Name=ENO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Retina;
RX   PubMed=3208766; DOI=10.1111/j.1432-1033.1988.tb14465.x;
RA   McAleese S.M., Dunbar B., Fothergill J., Hinks L., Day I.N.M.;
RT   "Complete amino acid sequence of the neurone-specific gamma isozyme of
RT   enolase (NSE) from human brain and comparison with the non-neuronal alpha
RT   form (NNE).";
RL   Eur. J. Biochem. 178:413-417(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=3385803; DOI=10.1002/jnr.490190409;
RA   van Obberghen E., Kamholz J., Bishop J.G. III, Zomzely-Neurath C.,
RA   Lazzarini R.A.;
RT   "Human gamma enolase: isolation of a cDNA clone and expression in normal
RT   and tumor tissues of human origin.";
RL   J. Neurosci. Res. 19:450-456(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2792767; DOI=10.1016/0378-1119(89)90217-5;
RA   Oliva D., Barba G., Barbieri G., Giallongo A., Feo S.;
RT   "Cloning, expression and sequence homologies of cDNA for human gamma
RT   enolase.";
RL   Gene 79:355-360(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Hematopoietic;
RX   PubMed=2045099; DOI=10.1016/0888-7543(91)90496-2;
RA   Oliva D., Cali L., Feo S., Giallongo A.;
RT   "Complete structure of the human gene encoding neuron-specific enolase.";
RL   Genomics 10:157-165(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=9074930; DOI=10.1101/gr.7.3.268;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 16-28; 33-50; 90-103; 163-179; 184-193; 240-262;
RP   270-285; 336-372 AND 413-422, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-434 (ISOFORM 1/2).
RX   PubMed=3653393; DOI=10.1016/0014-5793(87)80207-7;
RA   Day I.N.M., Allsopp M.T.E.P., Moore D.C.M., Thompson R.J.;
RT   "Sequence conservation in the 3'-untranslated regions of neurone-specific
RT   enolase, lymphokine and protooncogene mRNAs.";
RL   FEBS Lett. 222:139-143(1987).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-26, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   HYDROXYBUTYRYLATION AT LYS-233.
RX   PubMed=29775581; DOI=10.1016/j.molcel.2018.04.011;
RA   Huang H., Tang S., Ji M., Tang Z., Shimada M., Liu X., Qi S.,
RA   Locasale J.W., Roeder R.G., Zhao Y., Li X.;
RT   "p300-mediated lysine 2-hydroxyisobutyrylation regulates glycolysis.";
RL   Mol. Cell 70:663-678(2018).
RN   [18]
RP   INDUCTION BY HCMV UL38 (MICROBIAL INFECTION).
RX   PubMed=36459650; DOI=10.1073/pnas.2205789119;
RA   Moreno I. Jr., Rodriguez-Sanchez I., Schafer X., Munger J.;
RT   "Human cytomegalovirus induces neuronal enolase to support virally mediated
RT   metabolic remodeling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 119:e2205789119-e2205789119(2022).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS.
RX   PubMed=15289101; DOI=10.1016/j.jmb.2004.05.068;
RA   Chai G., Brewer J.M., Lovelace L.L., Aoki T., Minor W., Lebioda L.;
RT   "Expression, purification and the 1.8 angstroms resolution crystal
RT   structure of human neuron specific enolase.";
RL   J. Mol. Biol. 341:1015-1021(2004).
CC   -!- FUNCTION: Has neurotrophic and neuroprotective properties on a broad
CC       spectrum of central nervous system (CNS) neurons. Binds, in a calcium-
CC       dependent manner, to cultured neocortical neurons and promotes cell
CC       survival (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R)-2-phosphoglycerate = H2O + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:10164, ChEBI:CHEBI:15377, ChEBI:CHEBI:58289,
CC         ChEBI:CHEBI:58702; EC=4.2.1.11;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Mg(2+) is required for catalysis and for stabilizing the dimer.;
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 4/5.
CC   -!- SUBUNIT: Mammalian enolase is composed of 3 isozyme subunits, alpha,
CC       beta and gamma, which can form homodimers or heterodimers which are
CC       cell-type and development-specific. {ECO:0000269|PubMed:15289101}.
CC   -!- INTERACTION:
CC       P09104; Q9BSI4: TINF2; NbExp=2; IntAct=EBI-713154, EBI-717399;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}. Note=Can translocate to the plasma membrane in either
CC       the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P09104-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09104-2; Sequence=VSP_055482;
CC   -!- TISSUE SPECIFICITY: The alpha/alpha homodimer is expressed in embryo
CC       and in most adult tissues. The alpha/beta heterodimer and the beta/beta
CC       homodimer are found in striated muscle, and the alpha/gamma heterodimer
CC       and the gamma/gamma homodimer in neurons.
CC   -!- DEVELOPMENTAL STAGE: During ontogenesis, there is a transition from the
CC       alpha/alpha homodimer to the alpha/beta heterodimer in striated muscle
CC       cells, and to the alpha/gamma heterodimer in nerve cells.
CC   -!- INDUCTION: Levels of ENO2 increase dramatically in cardiovascular
CC       accidents, cerebral trauma, brain tumors and Creutzfeldt-Jakob disease.
CC   -!- INDUCTION: (Microbial infection) Activated by human cytomegalovirus
CC       (HCMV) UL38 in order to provide the virus with glycosyl building
CC       blocks. {ECO:0000269|PubMed:36459650}.
CC   -!- SIMILARITY: Belongs to the enolase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52388.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X13120; CAA31512.1; -; mRNA.
DR   EMBL; X14327; CAA32505.1; -; mRNA.
DR   EMBL; M36768; AAA52388.1; ALT_INIT; mRNA.
DR   EMBL; M22349; AAB59554.1; -; mRNA.
DR   EMBL; X51956; CAA36215.1; -; Genomic_DNA.
DR   EMBL; AK295220; BAH12015.1; -; mRNA.
DR   EMBL; BT007383; AAP36047.1; -; mRNA.
DR   EMBL; U47924; AAB51320.1; -; Genomic_DNA.
DR   EMBL; BC002745; AAH02745.1; -; mRNA.
DR   CCDS; CCDS8570.1; -. [P09104-1]
DR   PIR; JU0060; NOHUG.
DR   RefSeq; NP_001966.1; NM_001975.2. [P09104-1]
DR   PDB; 1TE6; X-ray; 1.80 A; A/B=2-434.
DR   PDB; 2AKM; X-ray; 1.92 A; A/B=2-434.
DR   PDB; 2AKZ; X-ray; 1.36 A; A/B=2-434.
DR   PDB; 3UCC; X-ray; 1.50 A; A/B=2-434.
DR   PDB; 3UCD; X-ray; 1.41 A; A/B=2-434.
DR   PDB; 3UJE; X-ray; 1.55 A; A/B=2-434.
DR   PDB; 3UJF; X-ray; 2.10 A; A/B=2-434.
DR   PDB; 3UJR; X-ray; 1.40 A; A/B=2-434.
DR   PDB; 3UJS; X-ray; 1.65 A; A/B=2-434.
DR   PDB; 4ZA0; X-ray; 2.31 A; A/B=1-434.
DR   PDB; 4ZCW; X-ray; 1.99 A; A/B=1-434.
DR   PDB; 5EU9; X-ray; 2.05 A; A/B/C/D/E/F/G/H=1-434.
DR   PDB; 5IDZ; X-ray; 2.63 A; A/B=1-434.
DR   PDB; 5TD9; X-ray; 2.32 A; A/B=1-434.
DR   PDB; 5TIJ; X-ray; 2.63 A; A/B=1-434.
DR   PDB; 7MBH; X-ray; 2.10 A; A/B=1-434.
DR   PDBsum; 1TE6; -.
DR   PDBsum; 2AKM; -.
DR   PDBsum; 2AKZ; -.
DR   PDBsum; 3UCC; -.
DR   PDBsum; 3UCD; -.
DR   PDBsum; 3UJE; -.
DR   PDBsum; 3UJF; -.
DR   PDBsum; 3UJR; -.
DR   PDBsum; 3UJS; -.
DR   PDBsum; 4ZA0; -.
DR   PDBsum; 4ZCW; -.
DR   PDBsum; 5EU9; -.
DR   PDBsum; 5IDZ; -.
DR   PDBsum; 5TD9; -.
DR   PDBsum; 5TIJ; -.
DR   PDBsum; 7MBH; -.
DR   AlphaFoldDB; P09104; -.
DR   SMR; P09104; -.
DR   BioGRID; 108340; 128.
DR   IntAct; P09104; 44.
DR   MINT; P09104; -.
DR   STRING; 9606.ENSP00000437402; -.
DR   BindingDB; P09104; -.
DR   DrugBank; DB02726; 2-Phosphoglycolic Acid.
DR   GlyGen; P09104; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P09104; -.
DR   MetOSite; P09104; -.
DR   PhosphoSitePlus; P09104; -.
DR   SwissPalm; P09104; -.
DR   BioMuta; ENO2; -.
DR   DMDM; 20981682; -.
DR   OGP; P09104; -.
DR   UCD-2DPAGE; P09104; -.
DR   EPD; P09104; -.
DR   jPOST; P09104; -.
DR   MassIVE; P09104; -.
DR   MaxQB; P09104; -.
DR   PaxDb; 9606-ENSP00000437402; -.
DR   PeptideAtlas; P09104; -.
DR   PRIDE; P09104; -.
DR   ProteomicsDB; 52198; -. [P09104-1]
DR   ProteomicsDB; 6473; -.
DR   Pumba; P09104; -.
DR   Antibodypedia; 3514; 2312 antibodies from 52 providers.
DR   DNASU; 2026; -.
DR   Ensembl; ENST00000229277.6; ENSP00000229277.1; ENSG00000111674.9. [P09104-1]
DR   Ensembl; ENST00000535366.5; ENSP00000437402.1; ENSG00000111674.9. [P09104-1]
DR   Ensembl; ENST00000538763.5; ENSP00000441490.1; ENSG00000111674.9. [P09104-2]
DR   Ensembl; ENST00000541477.5; ENSP00000438873.1; ENSG00000111674.9. [P09104-1]
DR   GeneID; 2026; -.
DR   KEGG; hsa:2026; -.
DR   MANE-Select; ENST00000229277.6; ENSP00000229277.1; NM_001975.3; NP_001966.1.
DR   UCSC; uc058knm.1; human. [P09104-1]
DR   AGR; HGNC:3353; -.
DR   CTD; 2026; -.
DR   DisGeNET; 2026; -.
DR   GeneCards; ENO2; -.
DR   HGNC; HGNC:3353; ENO2.
DR   HPA; ENSG00000111674; Group enriched (brain, retina).
DR   MIM; 131360; gene.
DR   neXtProt; NX_P09104; -.
DR   OpenTargets; ENSG00000111674; -.
DR   PharmGKB; PA27788; -.
DR   VEuPathDB; HostDB:ENSG00000111674; -.
DR   eggNOG; KOG2670; Eukaryota.
DR   GeneTree; ENSGT00950000182805; -.
DR   HOGENOM; CLU_031223_0_0_1; -.
DR   InParanoid; P09104; -.
DR   OMA; QHLGGAF; -.
DR   OrthoDB; 1093250at2759; -.
DR   PhylomeDB; P09104; -.
DR   TreeFam; TF300391; -.
DR   BioCyc; MetaCyc:HS10646-MONOMER; -.
DR   BRENDA; 4.2.1.11; 2681.
DR   PathwayCommons; P09104; -.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P09104; -.
DR   SignaLink; P09104; -.
DR   SIGNOR; P09104; -.
DR   UniPathway; UPA00109; UER00187.
DR   BioGRID-ORCS; 2026; 14 hits in 1156 CRISPR screens.
DR   ChiTaRS; ENO2; human.
DR   EvolutionaryTrace; P09104; -.
DR   GeneWiki; Enolase_2; -.
DR   GenomeRNAi; 2026; -.
DR   Pharos; P09104; Tbio.
DR   PRO; PR:P09104; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P09104; Protein.
DR   Bgee; ENSG00000111674; Expressed in cerebellar hemisphere and 172 other cell types or tissues.
DR   ExpressionAtlas; P09104; baseline and differential.
DR   Genevisible; P09104; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:CAFA.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0000015; C:phosphopyruvate hydratase complex; IBA:GO_Central.
DR   GO; GO:0001917; C:photoreceptor inner segment; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004634; F:phosphopyruvate hydratase activity; ISS:CAFA.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0006096; P:glycolytic process; ISS:CAFA.
DR   CDD; cd03313; enolase; 1.
DR   Gene3D; 3.20.20.120; Enolase-like C-terminal domain; 1.
DR   Gene3D; 3.30.390.10; Enolase-like, N-terminal domain; 1.
DR   HAMAP; MF_00318; Enolase; 1.
DR   InterPro; IPR000941; Enolase.
DR   InterPro; IPR036849; Enolase-like_C_sf.
DR   InterPro; IPR029017; Enolase-like_N.
DR   InterPro; IPR020810; Enolase_C.
DR   InterPro; IPR020809; Enolase_CS.
DR   InterPro; IPR020811; Enolase_N.
DR   NCBIfam; TIGR01060; eno; 1.
DR   PANTHER; PTHR11902; ENOLASE; 1.
DR   PANTHER; PTHR11902:SF10; GAMMA-ENOLASE; 1.
DR   Pfam; PF00113; Enolase_C; 1.
DR   Pfam; PF03952; Enolase_N; 1.
DR   PIRSF; PIRSF001400; Enolase; 1.
DR   PRINTS; PR00148; ENOLASE.
DR   SFLD; SFLDS00001; Enolase; 1.
DR   SFLD; SFLDF00002; enolase; 1.
DR   SMART; SM01192; Enolase_C; 1.
DR   SMART; SM01193; Enolase_N; 1.
DR   SUPFAM; SSF51604; Enolase C-terminal domain-like; 1.
DR   SUPFAM; SSF54826; Enolase N-terminal domain-like; 1.
DR   PROSITE; PS00164; ENOLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane; Cytoplasm;
KW   Direct protein sequencing; Glycolysis; Hydroxylation; Isopeptide bond;
KW   Lyase; Magnesium; Membrane; Metal-binding; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   CHAIN           2..434
FT                   /note="Gamma-enolase"
FT                   /id="PRO_0000134112"
FT   ACT_SITE        210
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   ACT_SITE        343
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         40
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         158
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         167
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         245
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         245
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   BINDING         293
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         293
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   BINDING         293
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         318
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         318
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT   BINDING         318
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         370..373
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         394
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         26
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         44
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15592455"
FT   MOD_RES         60
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         60
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         64
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         89
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         89
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         193
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         197
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17183"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17183"
FT   MOD_RES         202
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         228
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         228
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         233
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:29775581"
FT   MOD_RES         233
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         256
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         287
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         335
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         343
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         406
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   VAR_SEQ         61..104
FT                   /note="GVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKS -> A
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055482"
FT   VARIANT         264
FT                   /note="P -> A"
FT                   /id="VAR_002354"
FT   VARIANT         395
FT                   /note="T -> A"
FT                   /id="VAR_002355"
FT   CONFLICT        4
FT                   /note="E -> Q (in Ref. 1; CAA31512/CAA32505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        27..28
FT                   /note="AK -> GC (in Ref. 2; AAA52388)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127
FT                   /note="E -> N (in Ref. 2; AAA52388)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        240
FT                   /note="I -> M (in Ref. 1; CAA31512/CAA32505)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..12
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          18..26
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          29..34
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          43..45
FT                   /evidence="ECO:0007829|PDB:5TD9"
FT   TURN            54..56
FT                   /evidence="ECO:0007829|PDB:5TD9"
FT   HELIX           57..59
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           63..71
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           73..80
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           87..98
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          100..102
FT                   /evidence="ECO:0007829|PDB:5TD9"
FT   TURN            104..106
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           108..126
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           130..138
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          147..154
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           156..158
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          159..162
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          167..171
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           178..200
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           202..205
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          211..213
FT                   /evidence="ECO:0007829|PDB:3UJF"
FT   HELIX           220..234
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   TURN            237..239
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          241..245
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           248..251
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          254..257
FT                   /evidence="ECO:0007829|PDB:2AKM"
FT   TURN            259..262
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           267..269
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           273..286
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          289..293
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           301..309
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          312..318
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   TURN            319..323
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           325..333
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          338..342
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           344..347
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           350..362
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          366..370
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           380..388
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   STRAND          391..394
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           401..417
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           418..420
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           425..427
FT                   /evidence="ECO:0007829|PDB:2AKZ"
FT   HELIX           431..433
FT                   /evidence="ECO:0007829|PDB:2AKZ"
SQ   SEQUENCE   434 AA;  47269 MW;  6163DE81F5C67744 CRC64;
     MSIEKIWARE ILDSRGNPTV EVDLYTAKGL FRAAVPSGAS TGIYEALELR DGDKQRYLGK
     GVLKAVDHIN STIAPALISS GLSVVEQEKL DNLMLELDGT ENKSKFGANA ILGVSLAVCK
     AGAAERELPL YRHIAQLAGN SDLILPVPAF NVINGGSHAG NKLAMQEFMI LPVGAESFRD
     AMRLGAEVYH TLKGVIKDKY GKDATNVGDE GGFAPNILEN SEALELVKEA IDKAGYTEKI
     VIGMDVAASE FYRDGKYDLD FKSPTDPSRY ITGDQLGALY QDFVRDYPVV SIEDPFDQDD
     WAAWSKFTAN VGIQIVGDDL TVTNPKRIER AVEEKACNCL LLKVNQIGSV TEAIQACKLA
     QENGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL MRIEEELGDE
     ARFAGHNFRN PSVL
//
ID   HPDL_CLOSL              Reviewed;         897 AA.
AC   Q38HX4;
DT   11-JAN-2011, integrated into UniProtKB/Swiss-Prot.
DT   22-NOV-2005, sequence version 1.
DT   13-SEP-2023, entry version 55.
DE   RecName: Full=4-hydroxyphenylacetate decarboxylase glycyl radical subunit {ECO:0000303|PubMed:16878993};
DE            Short=HPA decarboxylase glycyl radical subunit;
DE            EC=4.1.1.83 {ECO:0000269|PubMed:16878993};
DE   AltName: Full=4-hydroxyphenylacetate decarboxylase catalytic beta subunit {ECO:0000303|PubMed:21823587};
DE   AltName: Full=4-hydroxyphenylacetate decarboxylase large subunit {ECO:0000312|EMBL:ABB05046.1};
DE   AltName: Full=p-hydroxyphenylacetate decarboxylase large subunit {ECO:0000250|UniProtKB:Q84F16};
GN   Name=csdB {ECO:0000312|EMBL:ABB05046.1};
OS   Clostridium scatologenes.
OC   Bacteria; Bacillota; Clostridia; Eubacteriales; Clostridiaceae;
OC   Clostridium.
OX   NCBI_TaxID=1548;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, ACTIVATION
RP   BY CSDA, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND SERINE
RP   PHOSPHORYLATION.
RC   STRAIN=ATCC 25775 / DSM 757 / JCM 1414 / NCIB 8855 / VPI 5393
RC   {ECO:0000312|EMBL:ABB05046.1};
RX   PubMed=16878993; DOI=10.1021/bi060840b;
RA   Yu L., Blaser M., Andrei P.I., Pierik A.J., Selmer T.;
RT   "4-Hydroxyphenylacetate decarboxylases: properties of a novel subclass of
RT   glycyl radical enzyme systems.";
RL   Biochemistry 45:9584-9592(2006).
RN   [2] {ECO:0007744|PDB:2Y8N, ECO:0007744|PDB:2YAJ}
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH HPA DECARBOXYLASE
RP   SMALL SUBUNIT AND 4-HYDROXYPHENYLACETATE, SUBUNIT, REACTION MECHANISM, AND
RP   ACTIVE SITE.
RX   PubMed=21823587; DOI=10.1021/ja203344x;
RA   Martins B.M., Blaser M., Feliks M., Ullmann G.M., Buckel W., Selmer T.;
RT   "Structural basis for a Kolbe-type decarboxylation catalyzed by a glycyl
RT   radical enzyme.";
RL   J. Am. Chem. Soc. 133:14666-14674(2011).
CC   -!- FUNCTION: Glycyl radical subunit of the HPA decarboxylase that
CC       decarboxylates phenylacetates with a hydroxyl group in the p-position.
CC       Active toward 4-hydroxyphenylacetate and 3,4-dihydroxyphenylacetate,
CC       forming 4-methylphenol and 4-methylcatechol, respectively. Is likely
CC       involved in the catabolism of aromatic amino acids such as tyrosine
CC       fermentation. 4-methylphenol (p-cresol) formation provides metabolic
CC       toxicity, which allows an active suppression of other microbes and may
CC       provide growth advantages for the producers in highly competitive
CC       environments (PubMed:16878993). The large subunit is the catalytic
CC       subunit that binds the substrate (PubMed:21823587).
CC       {ECO:0000269|PubMed:16878993, ECO:0000269|PubMed:21823587}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxyphenylacetate + H(+) = 4-methylphenol + CO2;
CC         Xref=Rhea:RHEA:22732, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:17847, ChEBI:CHEBI:48999; EC=4.1.1.83;
CC         Evidence={ECO:0000269|PubMed:16878993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22733;
CC         Evidence={ECO:0000305|PubMed:16878993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3,4-dihydroxyphenylacetate + H(+) = 4-methylcatechol + CO2;
CC         Xref=Rhea:RHEA:62556, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:17254, ChEBI:CHEBI:17612; EC=4.1.1.83;
CC         Evidence={ECO:0000269|PubMed:16878993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62557;
CC         Evidence={ECO:0000305|PubMed:16878993};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=358 uM for 4-hydroxyphenylacetate {ECO:0000269|PubMed:16878993};
CC         KM=388 uM for 3,4-dihydroxyphenylacetate
CC         {ECO:0000269|PubMed:16878993};
CC         Vmax=18.45 umol/min/mg enzyme for the decarboxylation of 4-
CC         hydroxyphenylacetate {ECO:0000269|PubMed:16878993};
CC         Vmax=9.12 umol/min/mg enzyme for the decarboxylation of 3,4-
CC         hydroxyphenylacetate {ECO:0000269|PubMed:16878993};
CC         Note=kcat is 135 sec(-1) for the decarboxylation of
CC         4-hydroxyphenylacetate. kcat is 67 sec(-1) for the decarboxylation of
CC         3,4-hydroxyphenylacetate. {ECO:0000269|PubMed:16878993};
CC   -!- SUBUNIT: Heterooctamer consisting of 4 large (HpdB) subunits and 4
CC       small (HpdC) subunits, arranged as a tetramer of heterodimers
CC       (PubMed:16878993, PubMed:21823587). Also forms a catalytically inactive
CC       homodimer (PubMed:16878993). {ECO:0000269|PubMed:16878993,
CC       ECO:0000269|PubMed:21823587}.
CC   -!- PTM: Requires the activating protein CsdA to generate the key active
CC       site glycyl radical that is involved in catalysis.
CC       {ECO:0000269|PubMed:16878993}.
CC   -!- PTM: Phosphorylated on serine. Phosphorylation may trigger the
CC       formation of the active heterooctamers and thereby regulates enzyme
CC       activity. {ECO:0000269|PubMed:16878993}.
CC   -!- SIMILARITY: Belongs to the glycyl radical enzyme (GRE) family. HPAD
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ227741; ABB05046.1; -; Genomic_DNA.
DR   RefSeq; WP_029163539.1; NZ_CP009933.1.
DR   PDB; 2Y8N; X-ray; 1.75 A; A/C=1-897.
DR   PDB; 2YAJ; X-ray; 1.81 A; A/C=1-897.
DR   PDBsum; 2Y8N; -.
DR   PDBsum; 2YAJ; -.
DR   AlphaFoldDB; Q38HX4; -.
DR   SMR; Q38HX4; -.
DR   STRING; 1548.CSCA_5035; -.
DR   BRENDA; 4.1.1.83; 9686.
DR   SABIO-RK; Q38HX4; -.
DR   GO; GO:0043722; F:4-hydroxyphenylacetate decarboxylase activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.20.70.20; -; 1.
DR   InterPro; IPR001150; Gly_radical.
DR   InterPro; IPR004184; PFL_dom.
DR   NCBIfam; NF033715; glycyl_HPDL_Lrg; 1.
DR   PANTHER; PTHR43641:SF2; DEHYDRATASE YBIW-RELATED; 1.
DR   PANTHER; PTHR43641; FORMATE ACETYLTRANSFERASE 3-RELATED; 1.
DR   Pfam; PF01228; Gly_radical; 1.
DR   Pfam; PF02901; PFL-like; 1.
DR   SUPFAM; SSF51998; PFL-like glycyl radical enzymes; 1.
DR   PROSITE; PS51149; GLY_RADICAL_2; 1.
DR   PROSITE; PS51554; PFL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Lyase; Organic radical; Phosphoprotein.
FT   CHAIN           1..897
FT                   /note="4-hydroxyphenylacetate decarboxylase glycyl radical
FT                   subunit"
FT                   /id="PRO_0000403691"
FT   DOMAIN          35..770
FT                   /note="PFL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00887"
FT   DOMAIN          778..897
FT                   /note="Glycine radical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00493"
FT   ACT_SITE        503
FT                   /note="Cysteine radical intermediate"
FT                   /evidence="ECO:0000305|PubMed:21823587"
FT   ACT_SITE        505
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:21823587"
FT   BINDING         344
FT                   /ligand="4-hydroxyphenylacetate"
FT                   /ligand_id="ChEBI:CHEBI:48999"
FT                   /evidence="ECO:0000269|PubMed:21823587,
FT                   ECO:0007744|PDB:2YAJ"
FT   BINDING         503
FT                   /ligand="4-hydroxyphenylacetate"
FT                   /ligand_id="ChEBI:CHEBI:48999"
FT                   /evidence="ECO:0000269|PubMed:21823587,
FT                   ECO:0007744|PDB:2YAJ"
FT   BINDING         536
FT                   /ligand="4-hydroxyphenylacetate"
FT                   /ligand_id="ChEBI:CHEBI:48999"
FT                   /evidence="ECO:0000269|PubMed:21823587,
FT                   ECO:0007744|PDB:2YAJ"
FT   BINDING         637
FT                   /ligand="4-hydroxyphenylacetate"
FT                   /ligand_id="ChEBI:CHEBI:48999"
FT                   /evidence="ECO:0000269|PubMed:21823587,
FT                   ECO:0007744|PDB:2YAJ"
FT   MOD_RES         873
FT                   /note="Glycine radical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00493,
FT                   ECO:0000305|PubMed:21823587"
FT   HELIX           35..45
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           54..65
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            66..68
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           71..84
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          100..103
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            111..113
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           116..126
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           136..139
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          157..160
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            161..163
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          164..167
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           168..170
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           171..178
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            182..184
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           186..194
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           200..208
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          219..225
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           229..250
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            258..262
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           263..294
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           299..315
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           323..338
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          343..347
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           351..354
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           356..364
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           370..385
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           393..396
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            397..399
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          408..413
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          417..419
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           423..434
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          442..446
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           452..462
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            463..465
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          469..473
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           474..485
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           486..488
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           492..496
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          499..501
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            502..504
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          505..507
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          509..516
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          519..526
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          534..539
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           540..548
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            549..551
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            554..556
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           571..603
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           608..612
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           616..619
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           623..625
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          635..639
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           641..654
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            655..657
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           663..671
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           673..675
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           679..682
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           696..708
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           717..734
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            752..754
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           755..760
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          777..781
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   TURN            784..786
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           791..798
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           803..805
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          812..815
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           817..820
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           822..838
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          843..849
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           851..859
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           861..863
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          868..870
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   STRAND          875..877
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           878..880
FT                   /evidence="ECO:0007829|PDB:2Y8N"
FT   HELIX           883..891
FT                   /evidence="ECO:0007829|PDB:2Y8N"
SQ   SEQUENCE   897 AA;  100637 MW;  DF8FC6541E459550 CRC64;
     MNVKETKLED VLKSRGIDMK DAYNISEADI PEAKESTQKL MDIYYTLKVT ADMEAAYWYN
     RTWWENDGEV IEVRRAKAVA ASLSHMTPTI LPYEKLVMNK TKNVRGAFPF PWVCASFFNA
     QAEALMNEVD APAENEADSV SVVGAGGGNV TESYGNVISI AKKFGMRKEE IPVLVKTSKP
     WEGISVEELS NKYSKMTPGY DQFKNIMESV ICMFDSFAIP QGREVINYYM PLQYGFDGII
     KLCDEKIAEV MGEAGDDGDF GMSRGYYYAA MKEITKGLSA WCENYSKRAK YLASIETDSE
     IKANYEKIEE VMGNIAHKKP ANFWEAIQMT LCCHFGVVNE DPQSGLSIGR LGQVLQPFYE
     KDVEDGIMTD EEVIELLELY RIKITCIECF ASAGVSGGVL SGNTFNNLSL GGQNYDGLSA
     VTPLEYLIVE AGMRNQTPQP TLSVLYDEKT PEDFLMKAAS CTKLGLGYPA WMNNQTGMNF
     MMRNYGPEGM DLHDARAWCL GGCLESAPGC FLPLEYNGKV TMIPGGASPT CGTGVHFIGM
     PKVLELVLTN GLDKRTGKQV YPPHNKKLDS YETMVNQWKE YMELTTDVVN RCNNIQMDIW
     RKYNMPAVNS LLKPDCFKKG KHIGTMGARY NSCINFESCG TITFVNSLSS IKKNVFDDSK
     FTIEEMTDAM LNNFGFKTAY ETEVFSPDFR ESTDKSTKYE KIFAACVNAP KYGNADKYAD
     EIFKAYHYYI YDMTHKFRSY YGKPLYLCQI SVSTHGPQGF VTLATADGRL AGTTYSDGSV
     SAAAGTDKNG IYAIFESATV YDHSMHQNAQ MNLKLHPTAV KGINGTRKLL DLVRAYMRKG
     GFHVQFNVVD SKTLRDAQLT PEKYRELMVR VAGFTQYWCE IGKPIQDEVI YRTEYDK
//
ID   MFNA_METJA              Reviewed;         396 AA.
AC   Q60358;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   08-NOV-2023, entry version 129.
DE   RecName: Full=L-tyrosine/L-aspartate decarboxylase {ECO:0000305};
DE            Short=TDC/ADC {ECO:0000255|HAMAP-Rule:MF_01610, ECO:0000305};
DE            EC=4.1.1.11 {ECO:0000255|HAMAP-Rule:MF_01610, ECO:0000269|PubMed:24891443};
DE            EC=4.1.1.25 {ECO:0000255|HAMAP-Rule:MF_01610, ECO:0000269|PubMed:15715981};
GN   Name=mfnA {ECO:0000255|HAMAP-Rule:MF_01610,
GN   ECO:0000303|PubMed:15715981}; OrderedLocusNames=MJ0050;
OS   Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM
OS   10045 / NBRC 100440) (Methanococcus jannaschii).
OC   Archaea; Euryarchaeota; Methanomada group; Methanococci; Methanococcales;
OC   Methanocaldococcaceae; Methanocaldococcus.
OX   NCBI_TaxID=243232;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=8688087; DOI=10.1126/science.273.5278.1058;
RA   Bult C.J., White O., Olsen G.J., Zhou L., Fleischmann R.D., Sutton G.G.,
RA   Blake J.A., FitzGerald L.M., Clayton R.A., Gocayne J.D., Kerlavage A.R.,
RA   Dougherty B.A., Tomb J.-F., Adams M.D., Reich C.I., Overbeek R.,
RA   Kirkness E.F., Weinstock K.G., Merrick J.M., Glodek A., Scott J.L.,
RA   Geoghagen N.S.M., Weidman J.F., Fuhrmann J.L., Nguyen D., Utterback T.R.,
RA   Kelley J.M., Peterson J.D., Sadow P.W., Hanna M.C., Cotton M.D.,
RA   Roberts K.M., Hurst M.A., Kaine B.P., Borodovsky M., Klenk H.-P.,
RA   Fraser C.M., Smith H.O., Woese C.R., Venter J.C.;
RT   "Complete genome sequence of the methanogenic archaeon, Methanococcus
RT   jannaschii.";
RL   Science 273:1058-1073(1996).
RN   [2]
RP   FUNCTION AS A TYROSINE DECARBOXYLASE, CATALYTIC ACTIVITY, COFACTOR,
RP   ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY, AND SUBUNIT.
RC   STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX   PubMed=15715981; DOI=10.1016/j.bbagen.2004.12.003;
RA   Kezmarsky N.D., Xu H., Graham D.E., White R.H.;
RT   "Identification and characterization of a L-tyrosine decarboxylase in
RT   Methanocaldococcus jannaschii.";
RL   Biochim. Biophys. Acta 1722:175-182(2005).
RN   [3]
RP   FUNCTION AS AN ASPARTATE DECARBOXYLASE, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RX   PubMed=24891443; DOI=10.1128/jb.01784-14;
RA   Wang Y., Xu H., White R.H.;
RT   "Beta-alanine biosynthesis in Methanocaldococcus jannaschii.";
RL   J. Bacteriol. 196:2869-2875(2014).
RN   [4] {ECO:0007744|PDB:3F9T}
RP   X-RAY CRYSTALLOGRAPHY (2.11 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL PHOSPHATE.
RG   Joint Center for Structural Genomics (JCSG);
RT   "Crystal structure of L-tyrosine decarboxylase MfnA (EC 4.1.1.25)
RT   (NP_247014.1) from Methanococcus jannaschii at 2.11 A resolution.";
RL   Submitted (NOV-2008) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the decarboxylation of L-tyrosine to produce
CC       tyramine for methanofuran biosynthesis (PubMed:15715981). Can also
CC       catalyze the decarboxylation of L-aspartate to produce beta-alanine for
CC       coenzyme A (CoA) biosynthesis (PubMed:24891443).
CC       {ECO:0000269|PubMed:15715981, ECO:0000269|PubMed:24891443}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-tyrosine = CO2 + tyramine; Xref=Rhea:RHEA:14345,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:58315,
CC         ChEBI:CHEBI:327995; EC=4.1.1.25; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01610, ECO:0000269|PubMed:15715981};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-aspartate = beta-alanine + CO2; Xref=Rhea:RHEA:19497,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:29991,
CC         ChEBI:CHEBI:57966; EC=4.1.1.11; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01610, ECO:0000269|PubMed:24891443};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01610,
CC         ECO:0000269|PubMed:15715981};
CC   -!- ACTIVITY REGULATION: Inhibited by hydroxylamine and O-
CC       methylhydroxylamine. {ECO:0000269|PubMed:15715981}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.6 mM for L-tyrosine {ECO:0000269|PubMed:15715981};
CC         KM=0.8 mM for L-aspartate {ECO:0000269|PubMed:24891443};
CC       pH dependence:
CC         Optimum pH is 7.5-8.5 for tyrosine decarboxylase activity.
CC         {ECO:0000269|PubMed:15715981};
CC       Temperature dependence:
CC         Thermostable. Retains full tyrosine decarboxylase activity after
CC         heating at 100 degrees Celsius for 10 minutes and 42% of its activity
CC         after 10 minutes at 110 degrees Celsius. Inactive after 10 minutes at
CC         121 degrees Celsius. {ECO:0000269|PubMed:15715981};
CC   -!- PATHWAY: Cofactor biosynthesis; methanofuran biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_01610, ECO:0000269|PubMed:15715981}.
CC   -!- PATHWAY: Cofactor biosynthesis; coenzyme A biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_01610, ECO:0000269|PubMed:24891443}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15715981}.
CC   -!- SIMILARITY: Belongs to the group II decarboxylase family. MfnA
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_01610}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L77117; AAB98031.1; -; Genomic_DNA.
DR   PIR; B64306; B64306.
DR   PDB; 3F9T; X-ray; 2.11 A; A/B=1-396.
DR   PDB; 6JY1; X-ray; 1.72 A; A=1-396.
DR   PDB; 6LDR; X-ray; 1.79 A; A=1-396.
DR   PDB; 6LDS; X-ray; 1.80 A; A=1-396.
DR   PDB; 6LDT; X-ray; 1.93 A; A=1-396.
DR   PDB; 6M4Y; X-ray; 2.10 A; A=1-396.
DR   PDBsum; 3F9T; -.
DR   PDBsum; 6JY1; -.
DR   PDBsum; 6LDR; -.
DR   PDBsum; 6LDS; -.
DR   PDBsum; 6LDT; -.
DR   PDBsum; 6M4Y; -.
DR   AlphaFoldDB; Q60358; -.
DR   SMR; Q60358; -.
DR   STRING; 243232.MJ_0050; -.
DR   PaxDb; 243232-MJ_0050; -.
DR   EnsemblBacteria; AAB98031; AAB98031; MJ_0050.
DR   KEGG; mja:MJ_0050; -.
DR   eggNOG; arCOG00027; Archaea.
DR   HOGENOM; CLU_028929_2_1_2; -.
DR   InParanoid; Q60358; -.
DR   OMA; DPHKMGL; -.
DR   PhylomeDB; Q60358; -.
DR   BioCyc; MetaCyc:MONOMER-12228; -.
DR   BRENDA; 4.1.1.11; 3260.
DR   BRENDA; 4.1.1.25; 3260.
DR   UniPathway; UPA00080; -.
DR   UniPathway; UPA00241; -.
DR   EvolutionaryTrace; Q60358; -.
DR   Proteomes; UP000000805; Chromosome.
DR   GO; GO:0004068; F:aspartate 1-decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB.
DR   GO; GO:0004837; F:tyrosine decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro.
DR   GO; GO:0015937; P:coenzyme A biosynthetic process; IBA:GO_Central.
DR   GO; GO:2001120; P:methanofuran biosynthetic process; TAS:UniProtKB.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   HAMAP; MF_01610; MfnA_decarbox; 1.
DR   InterPro; IPR020931; MfnA.
DR   InterPro; IPR002129; PyrdxlP-dep_de-COase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   NCBIfam; TIGR03812; tyr_de_CO2_Arch; 1.
DR   PANTHER; PTHR42735; -; 1.
DR   PANTHER; PTHR42735:SF6; SPHINGOSINE-1-PHOSPHATE LYASE 1; 1.
DR   Pfam; PF00282; Pyridoxal_deC; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Decarboxylase; Lyase; Pyridoxal phosphate;
KW   Reference proteome.
FT   CHAIN           1..396
FT                   /note="L-tyrosine/L-aspartate decarboxylase"
FT                   /id="PRO_0000147023"
FT   MOD_RES         245
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01610,
FT                   ECO:0000269|Ref.4"
FT   HELIX           11..24
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           28..30
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           44..52
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           60..62
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           64..80
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          87..92
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           94..114
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          124..128
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           133..142
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          145..149
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          155..157
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           159..168
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          173..179
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   TURN            181..183
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           189..199
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          202..206
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           210..212
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           214..216
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           219..221
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           232..234
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          237..241
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   TURN            243..247
FT                   /evidence="ECO:0007829|PDB:6LDR"
FT   STRAND          254..260
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           261..267
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          274..279
FT                   /evidence="ECO:0007829|PDB:3F9T"
FT   HELIX           289..326
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          331..333
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          336..343
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           347..356
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   STRAND          365..373
FT                   /evidence="ECO:0007829|PDB:6JY1"
FT   HELIX           380..393
FT                   /evidence="ECO:0007829|PDB:6JY1"
SQ   SEQUENCE   396 AA;  45050 MW;  41CB8DEE45A8BBC0 CRC64;
     MRNMQEKGVS EKEILEELKK YRSLDLKYED GNIFGSMCSN VLPITRKIVD IFLETNLGDP
     GLFKGTKLLE EKAVALLGSL LNNKDAYGHI VSGGTEANLM ALRCIKNIWR EKRRKGLSKN
     EHPKIIVPIT AHFSFEKGRE MMDLEYIYAP IKEDYTIDEK FVKDAVEDYD VDGIIGIAGT
     TELGTIDNIE ELSKIAKENN IYIHVDAAFG GLVIPFLDDK YKKKGVNYKF DFSLGVDSIT
     IDPHKMGHCP IPSGGILFKD IGYKRYLDVD APYLTETRQA TILGTRVGFG GACTYAVLRY
     LGREGQRKIV NECMENTLYL YKKLKENNFK PVIEPILNIV AIEDEDYKEV CKKLRDRGIY
     VSVCNCVKAL RIVVMPHIKR EHIDNFIEIL NSIKRD
//